New titanium vertebral body replacement device from ulrich medical

NewsGuard 100/100 Score

ulrich medical USA, Inc., today announced the release of the Omni VBR™ Implant System, a new titanium vertebral body replacement device that is intended for use in the thoracic and lumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body due to tumor or trauma. 

The Omni VBR implant joins a distinguished and growing portfolio of expandable cage technologies that ulrich medical USA currently has available for purposes of vertebral body replacement: obelisc® Implant System, ADDplus™ Implant System, Small VBR® Implant System and Large VBR® Implant System.   

"We are very pleased to introduce our fifth expandable corpectomy cage to the US market with the introduction of the Omni VBR implant. Expandable VBR technology is our core competency and we will continue to support, develop and defend our market leadership position in this sector of the complex spine market moving forward," said new hire Tom Carter, Senior Marketing Manager, ulrich medical USA.

The Omni VBR features a large central lumen that allows for maximum bone grafting while maintaining the expandability that has made ulrich's cages a market leader. This product currently has a variety of endplate angulation options, is sterile-packed and available in the following diameters: 19mm, 22mm, 26mm and 30mm with expansion ranges between 10 - 131mms.

Source:

ulrich medical USA, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Do neighborhood-level disparities in breast cancer–specific survival remain after accounting for individual, tumor, and treatment characteristics?